After 11 infants were exposed to measles at a pediatric clinic in Utah, the state Department of Health and Human Services helped to administer intramuscular immunoglobulin (IMIG) as postexposure prophylaxis (PEP) and ultimately developed a protocol for statewide use amid the ongoing outbreak.None of the exposed infants' parents declined IMIG for their child, there were no serious or localized systemic adverse events observed during administration or reported in follow-up calls with parents, and none of the infants contracted measles during the 21-day monitoring period.Findings come as Utah is experiencing the state's largest measles outbreak in 40 years, researchers noted.
After 11 infants were exposed to measles at a pediatric clinic in Utah, the state Department of Health and Human Services (DHHS) helped administer intramuscular immunoglobulin (IMIG) as postexposure prophylaxis (PEP) and ultimately developed a protocol for statewide use amid the ongoing outbreak.
None of the infants' parents declined IMIG for their child, and there were no serious or localized systemic adverse events during administration or reported in follow-up calls, reported Anna Jones, MD, of DHHS and the CDC, and colleagues. Notably, none of the infants contracted measles during the 21-day monitoring period.
